Perrigo Plc (NYSE: PRGO)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Perrigo Plc Returns vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Perrigo Plc Company Info
The Company is a global self-care supplier that manufactures and distributes over-the-counter generic consumer self-care products, nutritional products and prescription pharmaceuticals.
News & Analysis
A double miss and a guidance cut badly affected investor sentiment.
The company recovered nicely from the challenges of the coronavirus pandemic, as indicated by its Q4 results.
Rising costs make a tough business even tougher to turn a profit.
The drug company is collecting money at the same time it was able to pare back a big tax bill.
Find out what happened overnight that could move the stock market.
Analysts cooled on the company's prospects following its latest earnings report.
A disappointing earnings report pushed down shares of the over-the-counter medicine seller.
Investors liked the company's third-quarter earnings results.
Motley Fool Returns
Market-beating stocks from our award-winning analyst team.
Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 03/31/2023.
Discounted offers are only available to new members. Stock Advisor list price is $199 per year.
Calculated by Time-Weighted Return since 2002. Volatility profiles based on trailing-three-year calculations of the standard deviation of service investment returns.
Valuation
Earnings Transcripts
PRGO earnings call for the period ending September 30, 2021.
PRGO earnings call for the period ending July 3, 2021.
PRGO earnings call for the period ending April 3, 2021.
PRGO earnings call for the period ending December 31, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.